Skip to main content
Clinical Trials/EUCTR2015-000618-23-SE
EUCTR2015-000618-23-SE
Active, not recruiting
Phase 1

Treatment of osteoradionecrosis (ORN) with pentoxifylline and a-tocopherol (PENTO)

Västra Götalandsregionen/NÄ0 sites40 target enrollmentMarch 3, 2015

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Osteoradionecrosis
Sponsor
Västra Götalandsregionen/NÄ
Enrollment
40
Status
Active, not recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 3, 2015
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Västra Götalandsregionen/NÄ

Eligibility Criteria

Inclusion Criteria

  • Tumor\-free, prior radiation in head and neck region
  • Tissue\-scale (SH index) S0H2\-3 or S1H1\-3
  • Men and women age \=18 years
  • Understand the Swedish speaking and writing
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 20
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 20

Exclusion Criteria

  • Drug interactions with study medication
  • Inability to swallow tablets
  • Participation in a simultaneous and similar study
  • Alcohol or drug abuse
  • Mental illness or other conditions that the doctor/dentist deems incompatible with the study protocol

Outcomes

Primary Outcomes

Not specified

Similar Trials